BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 25727209)

  • 21. Regulatory roles for cytokine-producing B cells in infection and autoimmune disease.
    Lund FE; Garvy BA; Randall TD; Harris DP
    Curr Dir Autoimmun; 2005; 8():25-54. PubMed ID: 15564716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells and interferon-mediated autoimmunity.
    Gottenberg JE; Chiocchia G
    Biochimie; 2007; 89(6-7):856-71. PubMed ID: 17562353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin 21 as a target of intervention in autoimmune disease.
    Ettinger R; Kuchen S; Lipsky PE
    Ann Rheum Dis; 2008 Dec; 67 Suppl 3():iii83-6. PubMed ID: 19022821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of B-1a cells in autoimmunity.
    Duan B; Morel L
    Autoimmun Rev; 2006 Jul; 5(6):403-8. PubMed ID: 16890894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.
    Kim EY; Moudgil KD
    Cytokine; 2017 Oct; 98():87-96. PubMed ID: 28438552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice.
    Falcone M; Lee J; Patstone G; Yeung B; Sarvetnick N
    J Immunol; 1998 Aug; 161(3):1163-8. PubMed ID: 9686575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insights into the heterogeneity of human B cells: diverse functions, roles in autoimmunity, and use as therapeutic targets.
    Anolik JH; Looney RJ; Lund FE; Randall TD; Sanz I
    Immunol Res; 2009 Dec; 45(2-3):144-58. PubMed ID: 19350211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Both IFN-γ and IL-17 are required for the development of severe autoimmune gastritis.
    Tu E; Ang DK; Bellingham SA; Hogan TV; Teng MW; Smyth MJ; Hill AF; van Driel IR
    Eur J Immunol; 2012 Oct; 42(10):2574-83. PubMed ID: 22777705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The protective effect of IFN-gamma in experimental autoimmune diseases: a central role of mycobacterial adjuvant-induced myelopoiesis.
    Matthys P; Vermeire K; Heremans H; Billiau A
    J Leukoc Biol; 2000 Oct; 68(4):447-54. PubMed ID: 11037964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological therapies directed against cells in autoimmune disease.
    Hasler P
    Springer Semin Immunopathol; 2006 Jun; 27(4):443-56. PubMed ID: 16738955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
    Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of protective therapy for autoimmune diseases by targeted DNA vaccines encoding pro-inflammatory cytokines and chemokines.
    Karin N
    Curr Opin Mol Ther; 2004 Feb; 6(1):27-33. PubMed ID: 15011778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crossroads of B cell activation in autoimmunity: rationale of targeting B cells.
    Dörner T
    J Rheumatol Suppl; 2006 May; 77():3-11. PubMed ID: 16652439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ameliorated course of glucose-6-phosphate isomerase (G6PI)-induced arthritis in IFN-γ receptor knockout mice exposes an arthritis-promoting role of IFN-γ.
    Frey O; Mitera T; Kelchtermans H; Schurgers E; Kamradt T; Matthys P
    J Autoimmun; 2011 Mar; 36(2):161-9. PubMed ID: 21262564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Innate IFN-γ promotes development of experimental autoimmune encephalomyelitis: a role for NK cells and M1 macrophages.
    Dungan LS; McGuinness NC; Boon L; Lynch MA; Mills KH
    Eur J Immunol; 2014 Oct; 44(10):2903-17. PubMed ID: 25056715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B cell biology: implications for treatment of systemic lupus erythematosus.
    Anolik JH
    Lupus; 2013 Apr; 22(4):342-9. PubMed ID: 23553777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 38. [Interferon gamma as a regulator of immune cell function].
    Szuster-Ciesielska A; Kandefer-Szerszeń M
    Postepy Hig Med Dosw; 1999; 53(1):23-41. PubMed ID: 10352545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Interferon-gamma, the Th1/Th2 paradigm and autoimmune diseases].
    Billiau A
    Verh K Acad Geneeskd Belg; 1998; 60(4):271-85. PubMed ID: 9883078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of B cells in in vitro induction of IFN-gamma-producing CD4+ T cells specific to Listeria monocytogens: positive and IL-10-mediated negative regulation.
    Song F; Matsuzaki G; Mitsuyama M; Nomoto K
    Cell Immunol; 1994 Sep; 157(2):403-14. PubMed ID: 7915202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.